Cargando…
Reproducibility of planar (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy in patients with heart failure
PURPOSE: Despite its high prognostic value, widespread clinical implementation of (123)I-meta-iodobenzylguanidine (MIBG) myocardial scintigraphy is hampered by a lack of validation and standardization. The purpose of this study was to assess the reliability of planar (123)I-MIBG myocardial scintigra...
Autores principales: | Veltman, Caroline E., Boogers, Mark J., Meinardi, Joris E., Al Younis, Imad, Dibbets-Schneider, Petra, Van der Wall, Ernst E., Bax, Jeroen J., Scholte, Arthur J. H. A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3458210/ https://www.ncbi.nlm.nih.gov/pubmed/22790878 http://dx.doi.org/10.1007/s00259-012-2180-2 |
Ejemplares similares
-
The impact of acquisition time of planar cardiac (123)I-MIBG imaging on the late heart to mediastinum ratio
por: Dimitriu-Leen, Aukelien C., et al.
Publicado: (2015) -
(123)I-ioflupane brain SPECT and (123)I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders
por: Nuvoli, Susanna, et al.
Publicado: (2017) -
Bioavailability and toxicity after oral administration of m-iodobenzylguanidine (MIBG)
por: Kuin, A, et al.
Publicado: (1999) -
A convenient Simple Method for Synthesis of Meta-iodobenzylguanidine (MIBG)
por: Sheikholislam, Zahra, et al.
Publicado: (2013) -
Impact of Diabetes on Cardiac Sympathetic Innervation in Patients With Heart Failure: A (123)I meta-iodobenzylguanidine ((123)I MIBG) scintigraphic study
por: Paolillo, Stefania, et al.
Publicado: (2013)